A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients

Peter P. Reese, Ofole Mgbako, Adam Mussell, Vishnu Potluri, Zahra Yekta, Simona Levsky, Scarlett Bellamy, Chirag Parikh, Justine Shults, Karen Glanz, Harold I. Feldman, Kevin Volpp

Research output: Contribution to journalArticle

Abstract

Objective: Among chronic hemodialysis patients, hyperphosphatemia is common and associated with mortality. Behavioral economics and complementary behavior-change theories may offer valuable approaches to achieving phosphorus (PO4) control. The aim was to determine feasibility of implementing financial incentives and structured coaching to improve PO4 in the hemodialysis setting. Design and Methods: This pilot randomized controlled trial was conducted in 3 urban dialysis units for 10 weeks among 36 adults with elevated serum PO4 (median >5.5 mg/dL over 3 months). Interventions: Twelve participants each were randomized to: (1) financial incentives for lowering PO4, (2) coaching about dietary and medication adherence, or (3) usual care. PO4 was measured during routine clinic operations. Each incentives arm participant received the equivalent of $1.50/day if the PO4 was ≤5.5 mg/dL or >5.5 mg/dL but decreased ≥0.5 mg/dL since the prior measurement. The coach was instructed to contact coaching arm participants at least 3 times per week. Main Outcome Measures: The outcome measures included: (1) enrollment rate, (2) dropout rate, and (3) change in PO4 from beginning to end of 10-week intervention period. Results: Of 66 eligible patients, 36 (55%) enrolled. Median age was 53 years, 83% were black race, and 78% were male. Median baseline PO4 was 6.0 (interquartile range 5.6, 7.5). Using stratified generalized estimation equation analyses, the monthly decline in PO4 was -0.32 mg/dL (95% CI -0.60, -0.04) in the incentives arm, -0.40 mg/dL (-0.60, -0.20) in the coaching arm, and -0.24 mg/dL (-0.60, 0.08) in the usual care arm. No patients dropped out. All intervention arm participants expressed interest in receiving similar support in the future. Conclusions: This pilot trial demonstrated good feasibility in enrollment and implementation of novel behavioral health strategies to reduce PO4 in dialysis patients.

Original languageEnglish (US)
Pages (from-to)510-517
Number of pages8
JournalJournal of Renal Nutrition
Volume25
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Phosphorus
Motivation
Dialysis
Serum
Renal Dialysis
Behavioral Economics
Outcome Assessment (Health Care)
Hyperphosphatemia
Medication Adherence
Randomized Controlled Trials
Mentoring
Mortality
Health

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Reese, P. P., Mgbako, O., Mussell, A., Potluri, V., Yekta, Z., Levsky, S., ... Volpp, K. (2015). A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients. Journal of Renal Nutrition, 25(6), 510-517. https://doi.org/10.1053/j.jrn.2015.06.001

A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients. / Reese, Peter P.; Mgbako, Ofole; Mussell, Adam; Potluri, Vishnu; Yekta, Zahra; Levsky, Simona; Bellamy, Scarlett; Parikh, Chirag; Shults, Justine; Glanz, Karen; Feldman, Harold I.; Volpp, Kevin.

In: Journal of Renal Nutrition, Vol. 25, No. 6, 01.01.2015, p. 510-517.

Research output: Contribution to journalArticle

Reese, PP, Mgbako, O, Mussell, A, Potluri, V, Yekta, Z, Levsky, S, Bellamy, S, Parikh, C, Shults, J, Glanz, K, Feldman, HI & Volpp, K 2015, 'A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients', Journal of Renal Nutrition, vol. 25, no. 6, pp. 510-517. https://doi.org/10.1053/j.jrn.2015.06.001
Reese, Peter P. ; Mgbako, Ofole ; Mussell, Adam ; Potluri, Vishnu ; Yekta, Zahra ; Levsky, Simona ; Bellamy, Scarlett ; Parikh, Chirag ; Shults, Justine ; Glanz, Karen ; Feldman, Harold I. ; Volpp, Kevin. / A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients. In: Journal of Renal Nutrition. 2015 ; Vol. 25, No. 6. pp. 510-517.
@article{b9b2daa824ac4cde8e963c18448292c1,
title = "A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients",
abstract = "Objective: Among chronic hemodialysis patients, hyperphosphatemia is common and associated with mortality. Behavioral economics and complementary behavior-change theories may offer valuable approaches to achieving phosphorus (PO4) control. The aim was to determine feasibility of implementing financial incentives and structured coaching to improve PO4 in the hemodialysis setting. Design and Methods: This pilot randomized controlled trial was conducted in 3 urban dialysis units for 10 weeks among 36 adults with elevated serum PO4 (median >5.5 mg/dL over 3 months). Interventions: Twelve participants each were randomized to: (1) financial incentives for lowering PO4, (2) coaching about dietary and medication adherence, or (3) usual care. PO4 was measured during routine clinic operations. Each incentives arm participant received the equivalent of $1.50/day if the PO4 was ≤5.5 mg/dL or >5.5 mg/dL but decreased ≥0.5 mg/dL since the prior measurement. The coach was instructed to contact coaching arm participants at least 3 times per week. Main Outcome Measures: The outcome measures included: (1) enrollment rate, (2) dropout rate, and (3) change in PO4 from beginning to end of 10-week intervention period. Results: Of 66 eligible patients, 36 (55{\%}) enrolled. Median age was 53 years, 83{\%} were black race, and 78{\%} were male. Median baseline PO4 was 6.0 (interquartile range 5.6, 7.5). Using stratified generalized estimation equation analyses, the monthly decline in PO4 was -0.32 mg/dL (95{\%} CI -0.60, -0.04) in the incentives arm, -0.40 mg/dL (-0.60, -0.20) in the coaching arm, and -0.24 mg/dL (-0.60, 0.08) in the usual care arm. No patients dropped out. All intervention arm participants expressed interest in receiving similar support in the future. Conclusions: This pilot trial demonstrated good feasibility in enrollment and implementation of novel behavioral health strategies to reduce PO4 in dialysis patients.",
author = "Reese, {Peter P.} and Ofole Mgbako and Adam Mussell and Vishnu Potluri and Zahra Yekta and Simona Levsky and Scarlett Bellamy and Chirag Parikh and Justine Shults and Karen Glanz and Feldman, {Harold I.} and Kevin Volpp",
year = "2015",
month = "1",
day = "1",
doi = "10.1053/j.jrn.2015.06.001",
language = "English (US)",
volume = "25",
pages = "510--517",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients

AU - Reese, Peter P.

AU - Mgbako, Ofole

AU - Mussell, Adam

AU - Potluri, Vishnu

AU - Yekta, Zahra

AU - Levsky, Simona

AU - Bellamy, Scarlett

AU - Parikh, Chirag

AU - Shults, Justine

AU - Glanz, Karen

AU - Feldman, Harold I.

AU - Volpp, Kevin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: Among chronic hemodialysis patients, hyperphosphatemia is common and associated with mortality. Behavioral economics and complementary behavior-change theories may offer valuable approaches to achieving phosphorus (PO4) control. The aim was to determine feasibility of implementing financial incentives and structured coaching to improve PO4 in the hemodialysis setting. Design and Methods: This pilot randomized controlled trial was conducted in 3 urban dialysis units for 10 weeks among 36 adults with elevated serum PO4 (median >5.5 mg/dL over 3 months). Interventions: Twelve participants each were randomized to: (1) financial incentives for lowering PO4, (2) coaching about dietary and medication adherence, or (3) usual care. PO4 was measured during routine clinic operations. Each incentives arm participant received the equivalent of $1.50/day if the PO4 was ≤5.5 mg/dL or >5.5 mg/dL but decreased ≥0.5 mg/dL since the prior measurement. The coach was instructed to contact coaching arm participants at least 3 times per week. Main Outcome Measures: The outcome measures included: (1) enrollment rate, (2) dropout rate, and (3) change in PO4 from beginning to end of 10-week intervention period. Results: Of 66 eligible patients, 36 (55%) enrolled. Median age was 53 years, 83% were black race, and 78% were male. Median baseline PO4 was 6.0 (interquartile range 5.6, 7.5). Using stratified generalized estimation equation analyses, the monthly decline in PO4 was -0.32 mg/dL (95% CI -0.60, -0.04) in the incentives arm, -0.40 mg/dL (-0.60, -0.20) in the coaching arm, and -0.24 mg/dL (-0.60, 0.08) in the usual care arm. No patients dropped out. All intervention arm participants expressed interest in receiving similar support in the future. Conclusions: This pilot trial demonstrated good feasibility in enrollment and implementation of novel behavioral health strategies to reduce PO4 in dialysis patients.

AB - Objective: Among chronic hemodialysis patients, hyperphosphatemia is common and associated with mortality. Behavioral economics and complementary behavior-change theories may offer valuable approaches to achieving phosphorus (PO4) control. The aim was to determine feasibility of implementing financial incentives and structured coaching to improve PO4 in the hemodialysis setting. Design and Methods: This pilot randomized controlled trial was conducted in 3 urban dialysis units for 10 weeks among 36 adults with elevated serum PO4 (median >5.5 mg/dL over 3 months). Interventions: Twelve participants each were randomized to: (1) financial incentives for lowering PO4, (2) coaching about dietary and medication adherence, or (3) usual care. PO4 was measured during routine clinic operations. Each incentives arm participant received the equivalent of $1.50/day if the PO4 was ≤5.5 mg/dL or >5.5 mg/dL but decreased ≥0.5 mg/dL since the prior measurement. The coach was instructed to contact coaching arm participants at least 3 times per week. Main Outcome Measures: The outcome measures included: (1) enrollment rate, (2) dropout rate, and (3) change in PO4 from beginning to end of 10-week intervention period. Results: Of 66 eligible patients, 36 (55%) enrolled. Median age was 53 years, 83% were black race, and 78% were male. Median baseline PO4 was 6.0 (interquartile range 5.6, 7.5). Using stratified generalized estimation equation analyses, the monthly decline in PO4 was -0.32 mg/dL (95% CI -0.60, -0.04) in the incentives arm, -0.40 mg/dL (-0.60, -0.20) in the coaching arm, and -0.24 mg/dL (-0.60, 0.08) in the usual care arm. No patients dropped out. All intervention arm participants expressed interest in receiving similar support in the future. Conclusions: This pilot trial demonstrated good feasibility in enrollment and implementation of novel behavioral health strategies to reduce PO4 in dialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=84945486127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945486127&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2015.06.001

DO - 10.1053/j.jrn.2015.06.001

M3 - Article

VL - 25

SP - 510

EP - 517

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

IS - 6

ER -